Breast cancer treatment and its impact on survival in Morocco: a study over a decade

Author:

Mrabti Hind,Sauvaget CatherineORCID,Bendahhou Karima,Selmouni Farida,Muwonge Richard,Lucas Eric,Chami Youssef,Bennani Maria,Errihani Hassan,Benider Abdellatif,Bekkali Rachid,Basu Partha

Abstract

Abstract Background In Morocco, much progress has been made in breast cancer treatment. However, there is limited information on survival outcomes of breast cancer patients according to their therapeutic management. Methods A pattern-of-care study was conducted in Morocco’s two main oncology centres: Rabat and Casablanca and has shown that major progress has been made in the quality of care with survival rates comparable to those in developed countries. The present study focuses on the different therapeutic strategies used in breast cancer and their impact on prognosis. Patients were classified into two categories: those considered as appropriately managed and those who were not. Results A total of 1901 women with stage I to III breast cancer were included in this study, the majority (53%) were adequately managed and had better disease-free survival (DFS) rates than those who were not: DFS at 3 years (88% versus 62%) and at 5 years (80% versus 50%). Potential significant determinants of better management were: treatment in Rabat’s oncology centre, treatment between 2008 and 2012, being aged younger than 60 years, and early TN stage. Conclusion This study demonstrated the value of proper integrated and coordinated management in a comprehensive cancer centre, to improve breast cancer survival.

Publisher

Springer Science and Business Media LLC

Reference22 articles.

1. Registre des Cancers de la Région du Grand Casablanca. – Rapport d’Incidence 2013–2017. April 2022. https://www.contrelecancer.ma/site_media/uploaded_files/Registre_des_Cancers_de_la_Region_du_Grand_Casablanca_2013-2017.pdf.

2. Littlejohns P. Trastuzumab for early breast cancer: evolution or revolution? Lancet Oncol. 2006;7:22–3. https://doi.org/10.1016/s1470-2045(05)70533-7.

3. Foulon A, Theret P, Rodat-Despoix L, Kischel P. Beyond chemotherapies: recent strategies in breast Cancer Treatment. Cancers (Basel). 2020;12:2634. https://doi.org/10.3390/cancers12092634.

4. Selmouni F, Zidouh A, Belakhel L, et al. Tackling cancer burden in low-income and middle-income countries: Morocco as an exemplar. Lancet Oncol. 2018;19:e93e101. https://doi.org/10.1016/S1470-2045(17)30727-1.

5. Association Marocaine de Recherche et Formation en Oncologie Medicale. Guide des protocoles thérapeutiques en oncologie. Bulletin Marocain de l’Oncologie. 2021. http://amfrom.ma/assets/pdfs/Guide%20Th%C3%A9rapeutique.pdf.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3